Comparison Analysis of Lenvatinib Plus Transcatheter Arterial Chemoembolization Versus Atezolizumab Plus Bevacizumab as First‐Line Therapy for Intermediate‐Stage Hepatocellular Carcinoma Beyond the Up‐to‐Seven Criteria

LEN-TACE therapy may be one of the effective treatment strategies in intermediate-stage HCC patients beyond the up-to-seven criteria.

Authors

Institutions

Publication Details

Journal
Journal of Gastroenterology and Hepatology
Published
2025-05-31
DOI
https://doi.org/10.1111/jgh.17024
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparison Analysis of Lenvatinib Plus Transcatheter Arterial Chemoembolization Versus Atezolizumab Plus Bevacizumab as First‐Line Therapy for Intermediate‐Stage Hepatocellular Carcinoma Beyond the Up‐to‐Seven Criteria

Masahito Nakano, Seiichi Mawatari, Fumihito Hirai, Yasuhide Motoyoshi et al.
2 links
Journal of Gastroenterology and Hepatology
Hepatocellular Carcinoma Treatment and Prognosis
article

Comparison Analysis of Lenvatinib Plus Transcatheter Arterial Chemoembolization Versus Atezolizumab Plus Bevacizumab as First‐Line Therapy for Intermediate‐Stage Hepatocellular Carcinoma Beyond the Up‐to‐Seven Criteria

Masahito Nakano, Seiichi Mawatari, Fumihito Hirai, Yasuhide Motoyoshi, Hisamitsu Miyaaki, Takuya Kuwashiro, Michihiko Shibata, Tomoharu Yoshizumi, Shigeo Shimose, Shinji Itoh, Masao Iwao, Ryu Sasaki, Hiroshi Yatsuhashi, Rie Sugimoto, Masaru Harada, Satoshi Shakado, Hirokazu Takahashi, Takashi Niizeki, Yusuke Morita, Takumi Kawaguchi, Mizuki Endo, Akio Ido
article en

Abstract

LEN-TACE therapy may be one of the effective treatment strategies in intermediate-stage HCC patients beyond the up-to-seven criteria.

Journal of Gastroenterology and HepatologyVol. 40(8)
Kurume University (JP), Kagoshima University (JP), Kyushu University (JP), Saga University (JP), University of Occupational and Environmental Health Japan (JP), Oita University (JP), Fukuoka University (JP), National Hospital Organization Kyushu Cancer Center (JP), Nagasaki Medical Center (JP), Nagasaki University Hospital (JP), Nagasaki University (JP)
Good health and well-being
Openalex Percentile: Top 82%
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.